-
UTI Healthcare Fund Regular Plan Growth
Equity healthcare
Overview ( as on 08/10/25 )
NAV
₹288.71
Last change
₹-0.95 -0.0%
Fund Size (AUM)
1118.51 Cr
Performance
16.55% (5Y)
Fund Details
UTI Healthcare Fund Regular Plan Growth
as of 08/10/25
AUM
1118.51 Cr
Expense Ratio
2.26 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | -0.0% | 23.76% | 16.55% |
| BSE Healthcare TR INR | -2.62% | 22.66% | 16.82% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.42% |
Cipla Ltd |
5.68% |
Ajanta Pharma Ltd |
5.38% |
Lupin Ltd |
4.57% |
Dr Reddy's Laboratories Ltd |
4.06% |
Procter & Gamble Health Ltd |
3.99% |
Fortis Healthcare Ltd |
3.79% |
Glenmark Pharmaceuticals Ltd |
3.78% |
Apollo Hospitals Enterprise Ltd |
3.61% |
Alkem Laboratories Ltd |
3.41% |
Sector Allocation
Healthcare |
98.87% |
Basic Materials |
1.13% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
19.7% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
18.89% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
18.79% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
18.79% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
16.87% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
16.94% (5Y)
-
